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A STUDY ON BACTERIOLOGICAL PROFILE OF 
NECROTISING FASCIITIS IN A TERTIARY CARE HOSPITAL 
 
ABSTRACT 
 Necrotising Fasciitis is a rapidly progressing life threatening soft tissue 
infection with high mortality and morbidity. 
 
OBJECTIVES:  
 This study is to analyse the frequency of common bacteria causing necrotising 
fasciitis and antibiotic susceptibility pattern of aerobic isolates. This sudy would also 
provide an insight into the antimicrobial susceptibility pattern of aerobic isolates. 
 
MATERIALS AND METHODS: 
 This is a cross sectional study conducted at the Institute of Microbiology in 
association with the Institute of General Surgery, Madras Medical College, RGGGH, 
Chennai, during the period of October 2014 to September 2015. One hundred patients 
diagnosed with Necrotising Fasciitis were included. Tissue samples or wound swabs 
were collected and processed and identified based on standard microbiological 
procedures. 
 
RESULTS: 
 Out of one hundred patientsaffected76% were and 24 % were females. Type II 
Diabetes mellitus (DM) 59% was the most common co-morbid condition associated 
with necrotising fasciitis. Type II monomicrobial accounted for 69% and type I 
monomicrobialconstituted  26%  of infections. Klebsiella pneumoniae, 29% was the 
most common isolate. In Gram positive isolates 10% were Staphylococcus 
aureus.79% were ESBL producers and 42% were MRSA. Anaerobes accounted for 
13% of infections in Polymicrobialetiology. 
 
CONCLUSION:  
 Necrotising fasciitis is a lethal condition wherein high clinical 
suspicion,prompt diagnosis and extensive surgical and appropriate antibiotic therapy 
would be necessary to reduce mortality and duration of hospital confinement. 
 
KEY WORDS: 
 Necrotising Fasciitis, Type II DM,Klebsiella pneumoniae, ESBL, MRSA. 
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INTRODUCTION 
Necrotising Fasciitis (NF) or Necrotising soft tissue infection (NSTI) is 
infrequent but is a rapidly progressing lethal infection with necrosis of 
surrounding tissue. 
Necrotising Fasciitis is defined as infection of any of the layers within 
the soft tissue compartment (dermis, subcutaneous tissue, superficial fascia, 
deep fascia or muscle) which are associated with necrotising changes. This also 
includes infections of perineum of both men and women.(1) 
NF has a world-wide incidence of 0.001% and carries a mortality rate of 
17- 34% (2). It is associated with systemic toxicity and has a fulminant course. 
Prognosis of NF is dependent on early recognition and treatment. (3) 
Some of the predisposing factors are diabetes mellitus, 
immunocompromised state, usage of corticosteroids , intravenous drug abuse, 
trauma, malnutrition, burns, and atherosclerosis.(2) 
Early diagnosis is the key to manage the disease. NF presents with 
vague and non-specific symptoms rendering it more complicated to diagnose. 
Treatment involves a combination of extensive surgical debridement, and 
antibiotics based on the pathogens.(4) 
The prognosis hinges on accurate diagnosis, immediate surgery and 
initiation of appropriate antibiotics and intensive care. (5) 
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This study is focused on determining the common pathogenic bacteria 
and their antibiotic susceptibility pattern among the patients of Necrotising 
Fasciitis. Recognising the common bacterial causes of NF can be of immense 
assistance in selection of empirical antimicrobial therapy before the results of 
bacterial cultures are available. 
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AIMS OF THE STUDY 
(1) To determine the common aerobic and anaerobic bacteria causing 
Necrotising Fasciitis, 
(2) To analyse the antibiotic susceptibility of aerobic isolates. 
(3) Also to correlate the association of risk factors in patients with 
necrotising fasciitis. 
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REVIEW OF LITERATURE 
 HISTORY 
The earliest report of Necrotising Fasciitis dates back to the 5th century 
BC where Hippocrates describes complication of cellulitis(6). The first 
documented case happened in 1194 AD, when Duke Leopold of Austria 
developed the disease after his foot had been crushed by his horse. 
In 1764 Bauriene reported a case of scrotal gangrene which is 
considered to be the first case published in medical literature. 
Joseph Jones, medical officer in confederate army, at the time of 
American civil war in 1871, studied 2600 cases and described this disease 
which was common among soldiers due to conditions at the front. The term 
“Hospital Gangrene” was used then. This term Hospital Gangrene was widely 
in use, because of the condition inside many surgical wards were poor and 
many of the soldiers contracted the disease during their hospital stay. One other 
reason was that, they had, trauma of war injuries and amputation was 
indispensable, which inevitably lead to large wounds which were extremely 
susceptible to infections. (7).  
Jean Alfred Fournier, a French dermatologist in 1883 described scrotal 
NF in five young males. Fournier considered this condition as idiopathic in his 
description. Some of the historical descriptions applied to Fournier’s gangrene 
were periurethral, phelgmon, phagedema, or synergistic NF. (8) 
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In 1924, Frank L. Meleney, an American surgeon depicted the significance of 
extensive debridement of necrotic tissue to accomplish better results. 
“Meleney’s Gangrene” is synonyms with synergistic gangrene that affects the 
skin and subcutaneous tissue but not deep fascia except in advanced cases 
where invariably begins as a necrotic ulcer. (9) 
In 1952, the term “Necrotising Fasciitis” was coined by Dr.B.Wilson, 
an American surgeon. (10) 
Previously several authors advocated that the eponym Fournier to be 
restricted to cases of idiopathic peripheral gangrene and the term secondary 
necrotising fasciitis to be used where an established etiology was found. This 
classification is currently not in use.  
ANATOMY:(11) 
 
 
 
 
 
 
 
Figure 1 
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Epidermis of the skin is protected against infection by the mechanical 
barrier afforded by stratum corneum, since the epidermis itself lacks blood 
vessels. Erosion or disruption of this layer by bites, abrasion, burns, foreign 
bodies, primary dermatological disorders (herpes simplex, varicella, and 
ecthyma gangrenosum) surgery, vascular or pressure ulcers, allows penetration 
of bacteria to the underlying structures. 
Hair follicle also can serve as a portal either for components of normal 
flora (staphylococcus) or for extrinsic bacteria (Pseudomonas in hot-tub 
folliculitis). Bacteria infecting the epidermis are transmitted to the deeper 
structures through the lymphatics which leads to rapid superficial spread of 
erysipelas. 
The rich plexus of capillaries underneath the dermal papillae serves as a 
nutritional reservoir to the stratum germinativum, and the physiological 
responses of this plexus produce important signs and symptoms. The plexus 
serves as an access for bacteria to the circulation ultimately leading to local 
spread or bacteraemia. 
Exaggeration of any of these physiological processes by overwhelming 
levels of cytokines or bacterial toxins causes leukostasis, venous occlusion, and 
pitting oedema. Oedema with purple bullae, ecchymosis, and cutaneous 
anaesthesia indicating disruption of vascular integrity and requires exploration 
of the deeper structures for evidence of suggestive of necrotizing fasciitis or 
myonecrosis. An early diagnosis warrants a high level of clinical suspicion in 
7 
 
instances of unexplained fever, pain and tenderness in the soft tissue, even in 
the absence of acute cutaneous inflammation.  
EPIDEMIOLOGY 
The worldwide incidence of Necrotising Fasciitis is estimated to be 
0.001%. Some studies has reported 0.4-0.53 cases per 100,000. It is more 
predominant in males than in the female population. Incidence is higher in 
patients with diabetes mellitus. Though NF can occur at any site   in the body, 
extremities are more commonly affected followed by perineum and trunk. 
Mortality rate is reportedly around 17-34 %.(2). 
PATHOPHYSIOLGY 
NF is an infection of the deeper tissues that invariably results in 
progressive destruction of the muscle fascia and overlying subcutaneous fat. 
Muscle tissue is   frequently spared, due to its generous blood supply. Infection 
in NF characteristically spreads along the muscle fascia and the overlying 
tissue which initially appears unaffected. It is this unique feature that makes NF 
more complicated in diagnosing without surgical intervention. (12). 
Microbes invade the subcutaneous tissues, either through external 
trauma or direct spread from a perforated viscus, more commonly from colon 
or rectum or urogenital organ. Rapid bacterial growth within the superficial 
fascia results in release of mixture of enzymes endotoxins and exotoxins 
causing the spread of infection through the fascia. (13) 
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However fibrous attachments which exists between subcutaneous tissues 
and fasciae confines extension to areas like the scalp, hands, and feet. 
Deficiency of fibrous attachments in the limbs and trunk, nevertheless leads to 
extensive infection and tissue destruction. Infection also disseminates to venous 
circulation and lymphatic channels, resulting in oedema. This dissemination of 
bacteria results in thrombosis of blood vessels in dermal papilla, leading to 
ischemic necrosis and gangrene of dermis and subcutaneous fat. Thrombosis of 
small veins and arteries passing through the fascia causes profound skin 
ischaemia. (14) 
Thus poor microcirculation, ischaemia in affected tissues, ultimately 
leads to cell death and necrosis. This ischaemia of the skin is the cardinal 
phenomenon for the necrotising soft tissue infection as it progresses. The skin 
apparently appears normal in early pathological stages, inspite of extensive 
infection of the underlying fascia. Haemorrhagic bullae, ulceration, and skin 
necrosis are the subsequent manifestions with further involvement of the 
deeper structures. The initial clinical skin findings leads to underestimation of 
the tissue infection present,  even though thrombosis of penetrating vessels to 
the skin is the distinguishing feature in the pathology of NSTI. Thrombosis of 
vast numbers of dermal capillary beds must occur before skin changes 
implicative of necrosis occur.  In case of breach in fascia, infection of the 
muscle occurs leading to myositis. (15) 
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Vessel occlusion which causes skin infarction and necrosis, facilitates 
the growth of obligate anaerobes (ex. Bacteroides) while contributing to 
anaerobic metabolism of facultative organisms (ex. Escherichia coli), resulting 
in gangrene. Anaerobic metabolism results in production of gases like 
hydrogen and nitrogen, which are relatively insoluble gases that accumulates in 
subcutaneous tissues. (16) 
Also organisms that produce gas such as Clostridium species can lead to 
accumulation of subcutaneous gas, this had  resulted in the use of the 
terminology, gas gangrene. Infections caused by toxin-producing bacteria like 
Staphylococcus aureus and Streptococcus pyogenes can lead to toxic shock–
like syndrome. Thus, apparently confined infection can result in septic shock 
and multi-organ failure. (17). There are two distinct clinical presentations (11): 
(a) Those with no portal of entry and 
(b) Those with a defined portal of entry. 
Infections in the first category often begin deep at the site of a non-
penetrating minor trauma, such as a bruise or a muscle strain. Seeding of the 
site through transient bacteraemia is likely, however most patients deny 
antecedent streptococcal infection. These patients present with only severe pain 
and fever. Later in the course, the classic signs of necrotizing fasciitis, such as 
purple (violaceous) bullae, skin sloughing and progressive toxicity, develop. 
 In infections of the second type, Streptococcus pyogenes may reach the deep 
fascia from a site of cutaneous infection or penetrating trauma. These patients 
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have early signs of superficial skin infection with progression to necrotizing 
fasciitis. 
In either case, toxicity is severe, and renal impairment may precede the 
development of shock. In 20–40% of cases, myositis occurs concomitantly, 
and, as in gas gangrene serum creatine phosphokinase levels may be markedly 
elevated. Gas usually is not present when the cause is Streptococcus pyogenes 
or Methicillin Resistant Staphylococcus aureus. 
CLASSIFICATION 
Current classification of this infection is mainly based on the following: 
(a) The plane of tissue affected and the extent of invasion, 
(b) The anatomical site, 
(c) The causative pathogens. 
Deep soft tissue infections are classified either as necrotising fasciitis or 
necrotising myositis. 
Necrotising Fasciitis – rapid, extensive infection of the fascia 
underneath the adipose tissue. 
Necrotising myositis –principally involves the muscles otherwise 
spreads to adjacent soft tissue. (18) 
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Classification of soft tissue necrotizing infections(19) 
Table:1 
Classification Comments 
Anatomic location Cervical, thoracic, abdominal 
(Meleney’s), pelvis, Fournier’s 
gangrene. 
Depth of infection 
 
(a)Epidermis and dermis 
 
 
 
 
 
 
 
(b)Superficial fascia, subcutaneous 
tissue, subcutaneous fat, nerves, 
arteries, viens, deep fascia. 
 
 
(c)Muscle 
 
 
 
Erysipeals 
Impetigo 
Folliculitis 
Ecthyma 
Furunculosis 
Carbunculosis 
Cellulitis 
 
 
 Necrotising fasciitis 
 
 
 
Myonecrosis 
Microbial causes Types I, II, III, IV 
 
Classification of soft tissue infections by Lewis. (20) 
Infections of skin and subcutaneous tissue 
Progressive synergistic bacterial gangrene 
Chronic undermining burrowing ulcer (Meleney’s ulcer) 
Idiopathic scrotal gangrene (Fournier’s gangrene)  
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Infections involving subcutaneous tissue and fascia 
Haemolytic streptococcal gangrene 
Necrotizing fasciitis 
Gram-negative synergistic necrotizing cellulitis 
Clostridial cellulitis 
Infections involving muscle 
Clostridial myonecrosis 
Streptococcal myositis 
Classification based on Microbiology:(21) 
Table:2 
Types of NF Aetiology Organisms 
Type I Polymicrobial, 
synergistic, commonly 
bowel derived 
Mixed aerobes and 
anaerobes 
Type II Monomicrobial, skin or 
throat derived. 
Group A-β haemolytic 
Streptococcus(GAS) and 
Staphylococcus aureus 
Type III Gram negative, marine 
related organisms 
Vibrio spp 
Type IV (fungal) Trauma associated Candida spp 
immunocompromised, 
zygomycetes – 
immunocompetent 
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 TYPE I NECROTIZING FASCIITIS 
Type I or polymicrobial NF, frequently originates from intestinal flora 
and synergistic infection. Cultures of tissue will show a mixed growth of 
anaerobes and aerobes. It is a common type, frequently encountered in patients 
with diabetes mellitus. Type I NF usually occurs in perineum and trunk of the 
body. (22) 
TYPE II NECROTIZING FASCIITIS 
Type II monobacterial, is usually derived from skin or throat infection. 
The organism causing infection   will either be Group A/B hemolytic 
Streptococci alone or in combination with Staphylococcus aureus. Type II 
infections can also be caused by Staphylococcus aureus alone. 
Type II NF is frequently encountered in young and immuno competent 
individuals. Type II NF more often occurs due to MRSA. Strains of  MRSA 
that produce the 
Panton-Valentine leukocidin (PVL) toxin have been reported to cause 
necrotizing  fasciitis. This infection frequently involves extremities of the body.  
These patients are prone to toxic shock syndrome and multi organ dysfunction 
syndrome  (MODS). (23, 24) 
TYPE III NECROTIZING FASCIITIS 
This is the fulminant form of NF, caused by gram negative bacteria, 
commonly by marine-related organisms. Characteristically occurs after 
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punctured wound caused by fish or cut injury or an insect bite when exposed to 
the sea water. It is a hyper acute infection, leads to septic shock and Multi 
Organ Dysfunction Syndrome within 12 to 24 hours of injury. Early detection 
is the key to management, and any delay in diagnosis invariably leads to 100% 
mortality. (25). A study from Hong Kong showed 83% of their totals NF were 
type III infection. (26) 
TYPE IV NECROTIZING FASCIITIS 
Type IV NF occurs in immune compromised and also due severe trauma 
.Different types Fungi are the major causative agents of infection. It can rapidly 
spread and results in severe NF. Frequently caused by candida, Mucoror 
Rhizopus species. (27) 
CLINICAL MANIFESTATION 
Most NSTI occurs in the extremities, abdomen, groin, and perineum, 
however they can occur at any site of the body. Infection begins in the deep 
tissue planes, hence there might only be a least epidermal involvement. This 
makes NF complicated, as it has to be distinguished from non-necrotising skin 
infections and cellulitis. Minor trauma presenting as cellulitis may have deeper 
plane dissemination and may be missed initially. (28) 
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Clinical features suggestive of necrotising fasciitis: (29) 
Table:3 
Skin Pain General 
Erythema with ill-
defined margins 
Pain that extends past 
margin of apparent 
infection 
Fever with toxic appearance  
Tense oedema with or 
brown discharge 
Severe pain, out of 
proportion to dermal 
involvement or 
physical findings 
Altered mental state 
Lack of lymphangitis 
or lymphadenopathy 
Decreased pain or 
anaesthesia at 
apparent site of 
infection 
Tachycardia, tachypnea due 
to acidosis 
Vesicles or bullae, 
haemorrhagic bullae 
 Dehydration 
Necrosis  Decreased urine output 
Crepitus  Presentation with diabetic 
ketoacidosis. 
 
Erysipelas, being an infection of the superficial dermis, has well-defined 
borders and often blister. In case of cellulitis, there is predominance of 
erythema, lymphangitis with minimal blistering. 
Necrotizing fasciitis characteristically presents with patchy 
discolouration of the skin with pain and swelling, but lacks well defined margin 
and not associated with lymphangitis. (30).As the infection advances, it is more 
marked with the development of tense oedema, greyish-brown discharge, 
vesicles, bullae, necrosis, and crepitus. (31) 
16 
 
Haemorrhagic bullae and crepitus are serious signs, indicating extension 
to underlying fascia and muscle being comprised. (32). Crepitus being a late sign 
is only found in 18% of cases of NF. (33).Usually, there is no pus collection 
which eventually delays surgical consult or delayed intervention by the 
surgeon. 
Elliot et al and Wang et al in their two retrospective case series reported 
absence of blisters in 76% to 95% and 62% to 73% respectively, upon initial 
presentation. (34, 35) 
Patients with diabetic neuropathy may have minimal pain leading to a 
missed diagnosis. This peculiarly occurs in concealed sites of infection, like the 
perineum or oral cavity. An anaesthetic patch over the site of erythema is also 
sometimes described in NF. This is presumed to be due to infarction of 
cutaneous nerves in necrotic subcutaneous fascia and soft tissue. (36) 
 Some specific types of necrotizing fasciitis with their characteristic 
features are as follows: 
(a) Necrotizing Cellulitis: Necrotizing cellulitis, or haemolytic streptococcal 
gangrene, usually presents shortly after minor trauma. Patient’s findings are 
consistent with cellulitis, including erythema, warmth, and swelling. Unlike 
other cellulitis intense pain is common. May also progress to accumulation of 
gas distal to the wound and blebs containing dark serous fluid. (1) 
 (b) Streptococcal Myositis: Streptococcal myositis typically presents with 
severe local pain and toxaemia. Wounds present with foul odour, discoloration, 
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and oedema. Patients are prone to develop blebs and gangrene of the overlying 
skin, however the disease progression is typically slow. Muscle underneath no 
longer remains viable, and invariably requires excision. (1) 
(c) Clostridial Cellulitis: The most crucial historical presentation associated 
with clostridial cellulitis is severe pain which begins days after local tissue 
injury. This eventually leads to skin blebs filled with reddish brown foul 
smelling fluid. Cellulitis rapidly progresses within hours and patients become 
toxic. Though crepitus might be present, it’s not a universal finding. (1) 
(d)Progressive Bacterial Synergistic Gangrene or Meleney’s Gangrene: 
According to Baxter, Progressive Bacterial Synergistic Gangrene (PBSG) and 
Meleney’s ulcer represent variant forms of similar disease process, but has 
been described as two different entities. In spite of all the differences, clinical 
profiles were found to be similar. 
PBSG is a rapidly progressive infection due to non-haemolytic Streptococci, 
most commonly develops following abdominal surgeries with infected wound 
and is usually associated with haemolytic Staphylococci or gram-negative 
bacilli. This wound presents with a central necrotic area that is enveloped by 
purple, erythematous zones of skin. Wounds in addition,  possesses necrotic 
tracts which extends through the underlying tissue, ultimately leading to 
ulcerations at sites far from the primary lesion. 
(e)Fournier’s Gangrene: Fournier’s gangrene is an acute, rapidly progressive, 
and potentially fatal, infective necrotizing fasciitis affecting the external 
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genitalia, perineal, or perianal regions, most common in men although it can 
occur in women and children. Fournier’s Gangrene manifests as sudden pain in 
the scrotum, prostration, pallor, and pyrexia. Initially only the scrotum is 
involved, ungoverned, the cellulitis extends till entire scrotal coverings sloughs, 
leaving the testes exposed but healthy. One imperceptible feature of the 
presentation is the strong “repulsive, fetid odour” that is associated with this 
condition. Patients usually present with varying symptoms and signs including 
fever greater than 38 C, scrotal swelling, erythema, purulent wound discharge, 
and crepitation. (37) 
PREDISPOSING FACTORS AND CO-MORBID CONDITIONS 
The entry of pathogens occurs by trauma, insect bite, surgical incision, 
haematogenous spread from distant sites of infection has also been reported. (38)  
Some of the other predisposing factors are odontogenic infections, varicella 
lesions, intramuscular injections and bruises. (39). NF has been documented 
even in the absence of any trauma. (40) 
NF has even been reported after acupuncture. (41). This type of specific 
history is often only obtained if the physician directly questions the patient; 
otherwise, patients probably ignore or forget to acknowledge. 
Non-steroidal anti-inflammatory drug use has been a predisposing 
aetiology in severe necrotizing streptococcal infections. It is postulated that 
non-steroidal anti-inflammatory drugs impairs lymphocyte function. 
(42).Nevertheless it could be due to suppression of symptoms and signs of 
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inflammation which ultimately leads to delay in diagnosis, particularly in 
patients presenting early with vague symptoms. (43) 
Risk factors for NF in the paediatric population are malnutrition and 
skin infections such as varicella. (44, 45). It is necessary to emphasize that 
physicians should not exclude NF in normal healthy individuals with minor 
skin trauma. Those are the patients who usually go missed. 
RISK FACTORS FOR NECROTIZING FASCIITIS 
 Diabetes 
 Chronic disease 
 Immunosuppressive drugs (eg, prednisolone) 
 Age above 60 years 
 Malnutrition 
 Peripheral vascular disease 
 Intravenous drug misuse 
 Renal failure 
 Underlying malignancy 
 Obesity 
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PRECIPITATING EVENTS CAUSING NECROTIZING 
FASCIITIS 
Table:4 
Traumatic Non traumatic 
Surgery Soft tissue infections 
Minor invasive procedures (joint 
aspiration, accupunture) 
Burns 
Intravenous drug abuse Childbirth  
Penetrating injuries ( insect and 
animal bites) 
 
 
DIAGNOSIS: (11) 
The physical appearance and location of lesions within the soft tissues 
are important diagnostic clues. Other crucial considerations in narrowing down 
the differential diagnosis are the progression of the lesions as well as the 
patient’s travel history, animal exposure or bite history, age, underlying disease 
status, and lifestyle . 
 However, it is difficult to diagnose all infections of the soft tissues by 
history and inspection alone. Soft tissue radiography, CT and MRI may be 
useful in determining the depth of infection and should be performed if the 
patient has rapidly progressing lesions or evidence of a systemic inflammatory 
response syndrome. These tests are particularly important for defining a 
localized abscess or detecting gas in tissue. 
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But they may reveal only soft tissue swelling and hence are not specific 
for fulminant infections such as necrotizing fasciitis or myonecrosis caused by 
group A Streptococcus where gas may not found in lesions. 
Aspiration of the leading edge or punch biopsy with frozen section may 
also be helpful if the results of imaging tests are positive, however false-
negative results occur in ~80% of cases. Aspiration alone may be superior to 
injection and aspiration with normal saline. Frozen sections are particularly 
useful in distinguishing Staphyloccal Scalded Skin Syndrome (SSSS) from 
Toxic Epidermal Necrolysis (TEN) and are quite valuable in cases of 
necrotizing fasciitis. 
Laboratory risk indicators of Necrotising Fasciitis (LRINEC) score 
to discriminate between necrotizing and non-necrotizing soft-tissue 
infections: (1) 
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Table:5 
Value Score 
C-reactive protein, mg/dl 
<150 
 
0 
>150 4 
WBC count, cells/mm3 
<15 k 
 
0 
15-25 k 1 
>25 k 2 
Haemoglobin level, g/dl  
>13.5 0 
11-13.5 1 
<11 2 
Sodium level, mmol/L 
>135 0 
<135 2 
Creatinine level, mg/dl 
<1.6 0 
>1.6 2 
Glucose level, mg/dl 
<180 0 
>180 1 
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Risk Category based on the LRINEC score: 
Table:6 
Low <5 <50% chance of NF 
Intermediate 6-7 50-75% chance of NF 
High  8 >75% chance of NF 
 
Open surgical inspection, with debridement as indicated, is precisely the 
best way to determine the extent and severity of infection and to obtain 
materials for Gram’s staining and culture. Such an aggressive approach is 
necessary for fulminant infections where, associated systemic toxicity is 
encountered. 
MICROBIOLOGY 
Type I: This type is usually polymicrobial (aerobes and anaerobes). 
Enterobacteriaceae are the most common bacteria isolated while Klebsiella 
pneumonia, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa are 
the common gram negative organisms. In Gram positive Staphylococcus 
aureus, Enterococcus species, Streptococcus pyogenes are common. (46) 
Synergistic non-clostridial anaerobic myonecrosis, also known as 
necrotizing cutaneous myositis and synergistic necrotizing cellulitis, is a 
variant of necrotizing fasciitis caused by mixed aerobic and anaerobic bacteria 
with the exclusion of clostridial organisms. 
24 
 
Anaerobes: Bactroides  fragilisis the most common organism isolated. 
Clostridium spp, Peptostreptococcus spp, are the other organisms found in 
wounds of NF. Fusobacterium spp, viellonella  parvula, Prevotella brivia, 
Porphyromonas spp are the other less common anaerobes causing NF.(46) 
Bacteroides: Classified under Gram negative anaerobic non-sporing 
bacilli.  are strict anaerobes and are non-motile. They are pleomorphic, slender 
rods arranged singly or in pairs or short chains. Bacteroides are normal flora in 
human intestine. 
Bacteroides fragilis: This is the most frequent isolate in clinical 
specimens. Belongs to the family Bacteroidaceae. More often isolated from 
wound, pleural fluid, blood, brain abscesses, peritoneal fluid, urogenital 
infections and soft tissue infections. In general Bacteroides fragilis group occur 
below the diaphragm. 
Most of the infection requires breach in mucosal integrity which allows 
the organisms to gain access to deeper tissues. The hallmark of most but not all 
infections is the production of foul odour. (47) 
Virulence Factors: They produce capsule, endotoxin and succinic acid 
which inhibit phagocytosis and various enzymes that mediate tissue damage. 
(47) 
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IDENTIFICATION (47) 
On Anaerobic blood agar: white to grey white, entire convex 
translucent to semi opaque; non-haemolytic colonies. 
On Bacteroides Bile Esculin agar (BBE):colonies are >1mm, circular, 
entire, and either (a) low convex, dark grey zone (esculin hydrolysis) and 
sometimes precipitate bile. (b) glistening, convex, light to dark grey and 
surrounded by grey zone. 
Gram Stain: Gram negative, pale- staining, pleomorphic rods with 
rounded ends; occurs singly or in pairs; often described as safety pin 
appearance. 
Peptostreptococcus: Gram positive anaerobic cocci. Normal flora of the 
skin, mouth, intestine and vagina. These are recovered from various clinical 
infections such as puerperal sepsis, skin and soft tissue infections and brain 
abscess.  
PEPTOSTREPTOCOCCUS ANAEROBIUS:(47) 
Colonies on anaerobic blood agar: Colonies are grey-white, opaque; 
sweet, fetid odour; and they are usually larger than most anaerobic cocci. 
Gram Stain: Gram-positive, large coccobacillus; often in chains. 
Type II: It is a monobacterial, skin or throat derived infection. The 
causative organism will be either Group A/B haemolytic streptococci alone or 
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in combination with Staphylococci. Staphylococci alone can also cause this 
type of NF. (27) 
Group A Streptococci is the most common cause accounting for nearly 
60% of total cases of NF. Common serotypes include M types 1 and 3 which 
produces Streptococcal pyrogenic exotoxins.(48) 
Type III:  Type III includes monomicrobial infections involving the 
Clostridium species which are anaerobic bacteria that enters by external 
injuries deep wound or crush injury that results in local devascularisation, or 
surgical wounds particularly intestinal and obstetric. Clostridium infections are 
currently more frequent among drug addicts (49) and Clostridium perfringens is 
the most common bacterium causing type III NF.                               
Vibrio vulnificus is marine bacterium frequently isolated in Asia. Vibrio 
vulnificus also expresses capsular polysaccharides, toxins, enzymes, 
metalloproteases, lipopolysaccharides and cytolysin. Shiuan-Chih Chen et al in 
a retrospective study has documented 89 cases of necrotising fasciitis caused 
by Vibrio vulnificus. (50) 
Aeromonas hydrophila is found in fresh water or low salinity water and 
in the soil. The clinical symptoms caused by these two bacteria are similar. 
In a study from Hong Kong showed 83% of their totals NF were type 
III. (51). A case of type III NF of the forearm, caused by the Aeromonas sabori; 
had been reported. (27) 
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TypeIV: These are fungal infections, mainly due to Candida spp. and 
Zygomycetes. This type is found mainly in the immuno compromised host. 
Infections by these fungi occur after trauma, the clinical image is aggressive 
and rapidly extensive, and particularly in immuno compromised patients 
.Mucor and Rhizopus are the common Zygomycetes (27). 
Deepali Jain et al in a retrospective study has reported 18 cases of fungal 
necrotising fasciitis, out of which five were positive for Apophysomyces 
elegans and fifteen patients were immune competent.(52). 
Treatment: 
Resuscitation and supportive care: 
The main objective of resuscitation is to restore adequate perfusion of 
tissue and oxygen delivery. Invasive arterial pressure monitoring and central 
venous access may be required; haemodynamic resuscitation in patients 
presenting with sepsis secondary to NF are as suggested by the Surviving 
Sepsis Campaign. (19) 
Adequate nutritional support and treatment of nosocomial infections are 
important. Critical care admission is strongly recommended in view of the 
aggressive clinical course, high risk of multi organ failure, and significant 
mortality rate. 
Early and aggressive surgical exploration is essential in cases of 
suspected necrotizing fasciitis, myositis, or gangrene in order to (1) visualize 
the deep structures, (2) remove necrotic tissue, (3) reduce compartment 
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pressure, and (4) obtain suitable material for Gram’s staining and for aerobic 
and anaerobic cultures.  
Appropriate empirical antibiotic treatment for mixed aerobic–anaerobic 
infections could consist of ampicillin/sulbactam, cefoxitin, or the following 
combination: (1) clindamycin (600–900 mg IV every 8 h) or metronidazole 
(500 mg every 6 h) plus (2) ampicillin or ampicillin/sulbactam (1.5–3g IV 
every 6 h) plus(3) gentamicin (1–1.5 mg/kg every 8h) 
Antibiotic treatment should be continued until all signs of systemic 
toxicity have resolved, all devitalized tissue has been removed, and granulation 
tissue has developed.(11) 
Table:7 
Condition Primary Treatment  Alternative treatment 
Necrotising fasciitis 
(group A Streptoccocal) 
Clindamycin, 600-
900mg IV q6-8h,   
plus  
Penicillin G, 4 million 
units IV q4h. 
Clindamycin, 600-
900mg IV q6-8h,   
plus  
Cephalosporin (first or 
second generation). 
Necrotising Fasciitis 
(mixed aerobes and 
anaerobes) 
Ampicillin,2g IV q4h, 
plus, 
Clindamycin, 600-900 
mg IV q6-8h, 
plus  
Ciprofloxacin, 400mg 
IV q6-8h. 
Vancomycin, 1g IV q6h, 
plus, 
Metronidazole, 500 mg 
IV q6h, 
plus 
Ciprofloxacin, 400mg 
IV q6-8h. 
Gas gangrene Clindamycin, 600-
900mg IV q6-8h,  
 plus 
 Penicillin G, 4 million 
units IV q4h. 
Clindamycin, 600-
900mg IV q6-8h,  
 Plus 
Cefoxitin, 2g IV q6h. 
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I.V. IMMUNOGLOBULIN THERAPY 
The use of i.v. immunoglobulin (IVIG) is based on the mechanism that 
it can bind staphylococcal- and streptococcal derived exotoxin, thereby 
reducing the systemic cytokine release which invariably serves as triggering 
factor for systemic inflammatory response syndrome. There is very limited 
evidence which suggests a decreased mortality with the use of IVIG in patients 
of NF due to Streptococci. Use of IVIG in NF due to other bacterial aetiology 
has not been studied. At present use of IVIG is  restricted to critically ill patient 
with either Staphylococcal or Streptococcal NF. (53,54) 
HYPERBARIC OXYGEN (HBO) 
Hyperbaric oxygen is one of the preferred treatment for synergistic 
infections, particularly involving Clostridium spp., hyperbaric oxygen (HBO) 
switches off toxin production. HBO is considered to enhance the bactericidal 
action of neutrophils. Nevertheless, the evidence of benefit in non-Clostridial 
NF is poor. Moreover, there are very few hospitals with access to HBO units, 
appropriate staff, and chambers large enough for patients requiring intensive 
care support.(55) 
Surgical Debridement: 
Several studies had documented that the most important factor affecting 
mortality is timing and adequacy of initial surgical debridement. Delayed or 
inadequate debridement dramatically increases mortality. (56); 
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Radical debridement may necessitate limb amputation. Debridement 
eradicates the source of infection and toxins, and moreover debridement of 
infarcted tissue eventually improves the penetration of antibiotics. The 
infection is rarely eradicated after a single debridement and almost always 
requires serial debridements. Optimally, three debridements at intervals of 12–
36 h apart are required to establish control of gross infection. Reconstructive 
surgery should be considered, when the patient has been stabilized and the 
infection completely eradicated. Antibiotics cannot penetrate infected necrotic 
tissue due to the thrombogenic nature of the infection. Hence aggressive 
surgical debridement remains the first priority. (19) 
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MATERIALS AND METHODS 
ETHICS CONSIDERATION 
The study protocol was approved before the commencement of this 
study, by the Institutional Ethics Committee, Madras Medical College, Rajiv 
Gandhi Government General Hospital, Chennai. Informed consent was 
obtained from all the patients included in the study. 
STUDY DESIGN 
This is a cross-sectional study conducted in the Institute of 
Microbiology in association with the Institute of General surgery. 
DURATION OF THE STUDY 
Study duration was one year, from October 2014 to September 2015. 
INCLUSION CRITERIA 
Patients in the age group 18 years and above were included in the study. 
Patients clinically diagnosed as necrotising fasciitis. 
EXCLUSION CRITERIA 
 Patients on antibiotic therapy for one week were excluded. 
SAMPLES COLLECTED: 
Tissue samples were obtained during wound debridement, (or) wound 
swabs were obtained from deeper areas of lesion. 
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These tissue specimens were collected during wound debridement. 
Swabs were taken from deeper areas of the lesion along the leading edge, after 
cleaning the wound with sterile saline transported to the laboratory and 
inoculated in Brain heart infusion broth (BHI) and in Robertson’s cooked meat 
medium (RCM). Two tissue bits (or) two swabs from each patients were 
collected . 
SPECIMEN PROCESSING & METHODOLOGY 
Direct Gram Staining was performed for all the specimens collected. 
AEROBIC CULTURE 
Tissue samples were homogenised and plated onto, 
(i)Mac Conkey agar plate  
(ii)Blood agar plate and kept in candle jar. Both were incubated at 37ºC 
overnight and observed for growth. 
      In Case of wound swabs, they were plated onto 
 (i) Mac Conkey agar plate, 
(ii) Blood agar plates- placed in candle jar and both were incubated at 37ºC, 
overnight  
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IDENTIFICATION 
Gram’s staining was performed from growth obtained. 
Gram Positive cocci were initially subjected to  
● Catalase test 
Catalase positive Gram positive cocci were further subjected to the 
following standard biochemical and microbiological tests; 
(a) Slide and tube coagulase, 
(b) Urease test, 
(c) Mannitol fermentation test, 
(d) Phenolphthalein phosphatase test, 
(e) Bacitracin susceptibility test using 0.04U disk. 
Catalase negative Gram positive organisms were subjected further to the 
following biochemical tests; 
(a) Bile-esculin hydrolysis, 
(b) Heat tolerance test, 
(c) Growth in 6.5% bile, 
(d) PYR test (pyrolidonyl-beta-naphtylamide), 
(e) Carbohydrate fermentation tests using Mannitol, Arabinose, sorbitol, 
Pyruvate and Raffinose. 
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Antibiotic susceptibility tests were performed by Kirby Bauer’s disk diffusion 
method on Muller-Hinton agar plate according to CLSI guidelines. 
PREPARATION OF INOCULUM FOR SENSITIVITY TESTING 
A single colony of the test organism was picked up with sterile loop and 
suspended in peptone water and incubated at 37ºC for 2hrs. The turbidity of the 
suspension was adjusted to 0.5 Mac Farland’s standard (1.5 x 108 CFU/ml). 
This suspension was spread onto Mueller-Hinton agar plate. A minimum of six 
antibiotic disks were placed on each MHA plates and were incubated 
overnight. The zone of inhibition was measured and interpreted as per CLSI 
(Clinical Laboratory Standards Institute) guidelines. 
The control strain used was; 
Staphylococcus aureus (ATCC 25923) 
Panel of antibiotics included for testing antimicrobial sensitivity of Gram 
positive cocci. 
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Table:8 
Antibiotics Disc 
Content 
Zone of Inhibition 
  Sensitive Intermediate Resistance 
Penicillin 10 units ≥29 - ≤28 
Erythromycin 15µg ≥23 14-22 ≤13 
Cefoxitin 30µg ≥22 - ≤21 
Ciprofloxacin 5µg ≥21 16-20 ≤15 
Co-trimoxozole 1.25/23.75µg ≥16 11-15 ≤10 
Amikacin 30µg ≥17 15-16 ≤14 
High level 
gentamicin 
120µg ≥10 7-9 ≤6 
Chloromphenicol 30µg ≥18 13-17 ≤12 
 
Stapylococcus aureus strains were screened for Methicillin resistance. 
DETECTION OF METHICILLIN RESISTANT 
STAPHYLOCOCCUS AUREUS 
CEFOXITIN DISC METHOD(53) 
Colonies of Staphylococcus aureus(test isolate) were inoculated in 
peptone water and matched with 0.5 Mac Farland standard. The suspension 
was streaked onto cation adjusted Muller-Hinton agar plates. And 
Staphylococcus aureus ATCC 25923 (Control) was also cultured onto another 
separate cation adjusted MHA. Cefoxitin disc (30 µg) was placed on the lawn 
culture of both the test and control isolates and incubated at 33-35ºC overnight. 
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INTERPRETATION 
As per CLSI guidelines, 
Zone of inhibition: ≥22mm (mec A negative) 
Zone of inhibition: ≤21mm (mec A positive) 
Cefoxitin is used as a surrogate marker for mec A- mediated oxacillin 
resistance. Isolates that test as mec A positive should be reported as oxacillin 
(not cefoxitin) resistant. 
MRSA isolates were to Minimum Inhibitory Concentration by E-test 
method. 
E-TEST (EPSILOMETER TEST): VANCOMYCIN EZY MIX 
STRIP VAN, HI-MEDIA 
 It is a unique Minimum Inhibitory Concentration determination paper 
strip coated with Vancomycin in a predefined quantitative gradient. MIC can 
be determined in the range of  0.016mcg/ml to 256mcg/ml, on testing against 
the test organism. 
QUALITY CONTROL 
ATCC Staphylococcus aureus  25923. 
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PROCEDURE 
 MRSA strains of Staphylococcus aureus were inoculated in peptone 
water and incubated for two hours at 37ºC and then streaked onto cation 
adjusted Mueller-Hinton agar plates using a sterile cotton swab.  
 Ezy MIC strips were brought to room temperature 15 minutes before 
use. Using an applicator provided in the kit bag, the Ezy MIC strip was placed 
on the plate seeded with the MRSA strain. The plates were then incubated at 
33º-35ºC overnight. 
    Control strain of ATCC Staphylococcus aureus 25923 was also tested 
similarly. 
INTERPRETATION 
Sensitive-2µg, 
Intermediate-4-8µg, 
Resistant- >16µg. 
GRAM NEGATIVE ORGANISMS  
The following preliminary and standard biochemical tests were performed; 
(a) Catalase test, 
 (b) Oxidase test, 
(c) Motility by hanging drop method, 
(d) Indole test, 
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(e) Methyl red test, 
(f) Voges proskeur test, 
(g) Citrate utilization test, 
(h) Urease hydrolysis test, 
(i) Hugh-leifsons of test, 
(j) Mannitol motility test 
(k) Lysine decarboxylase, Ornithine decarboxylase, Arginine dihydrolase,tests 
 (l) Carbohydrate fermentation tests using Glucose, Sucrose, Lactose, 
Maltose, Mannose fermentation tests were also performed. 
Acinetobacter baumanniwas speciated by the following tests; 
(a) Growth at 44ºC, 
(b) Presence of β-hemolysis, 
(c) 10% OF lactose utilisation test, 
(d) Malonate utilisation test. 
Antibiotic susceptibility tests were performed by Kirby Bauer’s disk 
diffusion method on Mueller- Hinton agar plate according to CLSI guidelines. 
The following organisms were used as controls: 
(1) Escherichia coli (ATCC 25922), 
(2) Pseudomonas aeruginosa (ATCC 27853) 
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PANEL OF ANTIBIOTICS INCLUDED FOR TESTING 
ANTIMICROBIAL SENSITIVITYOF GRAM 
NEGATIVEBACILLI 
Table:9 
Antibiotics Disk content 
Gram negative 
bacilli Diameter of zone of inhibition in mm 
   Sensitive 
Intermediat
e 
Resistan
t 
Amikacin 30µg  ≥17 15-16 ≤14 
Gentamicin 10µg  ≥15 13-14 ≤12 
Ciprofloxacin 5µg  ≥21 18-20 ≤17 
Cotrimoxozole 1.25/23.75µg  ≥16 11-15 ≤10 
Cefotaxime 30µg 
Enterbacteiacea
e ≥26 23-25 ≤22 
Acinetobacter 
sp. ≥23 15-22 ≤14 
Ceftazidime 30µg 
Enterbacteiacea
e ≥21 18-20 ≤17 
P.aeruginosa& 
Acinetobacter 
sp. 
 
≥18 15-17 ≤14 
 
 
Imipenem 
 
10µg 
Enterbacteiacea
e ≥23 20-22 ≤19 
P.aeruginosa ≥19 16-18 ≤15 
Acinetobacter 
sp. ≥16 14-15 ≤13 
Piperacilin-
Tazobactum 100/10µg  ≥21 18-20 ≤17 
 
Gram negative organisms which were resistant to 
cefotaxime/ceftazidime were subjected for confirmatory test to detect ESBL 
production by combination disk method. 
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PHENOTYPIC ESBL CONFIRMATORY TEST 
ANTIBIOTICS USED 
(1) Cefotaxime (30µg) 
(2) Cefotaxime/Clavulunate (30/10µg) 
(3) Ceftazidime (30µg) 
(4) Ceftazidime/Clavulunic acid (30/10µg) 
DETECTION OF EXTENDED SPECTRUM BETA LACTAMASE 
PRODUCTION 
Using sterile loop five to six colonies of  similar morphology of the test 
organism were picked up and inoculated in peptone water and incubated at 
37ºC for 2-4hrs and then the suspension was matched with 0.5 Mac Farland 
standard (1.5x108cfu/ml). Lawn culture was performed on MHA plate. 
Cefotaxime (30 µg), cefotaxime/clavulanate (30/10 µg) and Ceftazidime (30 
µg), Ceftazidime/clavulanate (30/10 µg) disks were placed on the plate with 
24mm gap between each disks and incubated at 37ºC overnight. 
INTERPRETATION:(53) 
A zone difference of   ≥ 5mm around the Cefazidime/Ceftazidime-
Clavulanate disks than Ceftazidime and a zone difference of ≥3mm around 
cefotaxime disks than Cefotaxime/Clavulanate is phenotypical confirmed to be 
due to ESBL production. 
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ANAEROBIC CULTURE: (48) 
Wound swabs or tissue samples were collected and inoculated in 
Robertson’s cooked meat medium and then were transported to the laboratory. 
Tissue specimens or swabs inoculated in RCM were plated onto 
anaerobic blood agar plates (blood agar with gentamicin and vitamin K). These 
plates were placed inside a Macintosh jar, along with a blood agar plate on 
which Pseudomonas aeruginosa was streaked as control. Anaerogas was kept 
inside the Macintosh jar, then closed and sealed with petroleum jelly and 
incubated at 37ºC for 48-72hrs and observed for growth. 
Growth obtained were subjected to Gram staining. 
Gram stain exhibiting Gram positive cocci, were initially subjected to, 
Catalase test 
The isolate were then, sub cultured onto anaerobic blood agar plate and 
the following  presumptive antibiotic identification disks were placed on the 
plate. 
Kanamycin, (1mg) 
Colistin, (10 µg) 
Vancomycin, (5µg) disks. 
Also sodium polyantheol sulfonate (SPS) was placed near colistin disk. 
This SPS disk was used for rapid identification of Peptostreptococcus 
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anaerobius, growth which is inhibited by SPS. Pseudomonas aeruginosa was 
streaked onto another blood agar plate as control. The plates were incubated 
anaerobically in Macintosh jar with Anaerogas at 37ºC for 48-72hrs. 
       Gram stain showing Gram negative bacilli were similarly subjected to 
catalase test and sub cultured onto anaerobic blood agar plate and the same 
identification disks were used. In addition to the other disks, nitrate disk was 
also placed and incubated anaerobically in Macintosh jar with Anaerogas at 
37ºC for 48-72hrs. 
Growth obtained were also tested for aerotolerance. Colonies were 
streaked onto chocolate agar plate and incubated in 5-10% of carbon dioxide at 
37ºC overnight. Since there was no growth observed in these plates the isolates 
were considered to be obligate anaerobes. 
Identification of Anaerobes: (48) 
Table:10 
Organisms 
Cell 
shape 
Kanamycin(1 
mg) 
Vancomycin(5µg) 
Colistin 
(10 mg) 
Nitrate SPS Catalase 
Bacteroides 
fragilis 
Bacilli R R R - - -Ve 
Peptostreptococcus 
anaerobius 
Cocci R S R - S -Ve 
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RESULTS 
 
This cross-sectional study was conducted at the Institute of 
Microbiology in association with the Institute of General Surgery at Madras 
Medical College, RGGGH, Chennai. Duration of the study was one year, from 
October 2014 to September 2015. Study population included one hundred 
patients with Necrotising Fasciitis. 
Age Distribution among the study population: (n=100)  
Figure 2 
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Age Distribution among the study population: (n=100) 
Table:11 
 
Age Distribution 
(n=100) 
Frequency Percentage 
 20 Years 2 2 
23 – 30 Years 6 6 
31-40 Years 4 4 
41-50 Years 19 19 
51-60 Years 24 24 
61-70 Years 20 20 
71-80 Years 21 21 
81-90 Years 4 4 
P value 
One Smaple t- Test 
0.4431 
 
 Majority of the patients belonged to the age group of 51-60 years of age 
(n=24, 24%) with a mean age of 58.35 years. The minimum age was 18 years 
and the maximum was 86 years. Since p value is > 0.05 as per one sample t 
test, the age distribution was not considered statistically significant. 
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Gender Distribution of the study population: (n=100) 
 
Figure 3 
 
 
Gender Distribution of the study population: (n=100) 
Table:12 
Gender Distribution Frequency Percentage 
Male 76 76 
Female 24 24 
Total 100 100 
P value 
One Sample Z-Test 0.0044 
 
Majority of the patients were male (n=76, 76%) and the rest were 
females (n=24, 24%). By conventional criteria gender distribution is taken as 
statistically significant as the P-value (0.0044) was lower than the significance 
level (0.05) by one sample Z test. 
76
24
Gender Distribution
Male Female
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Figure 4 
 
Co-Morbid Conditions: (n=100) 
Table:13 
Co-morbidity (n=100) Frequency Percentage 
Idiopathic 5 5  
DM 59 59 
HT 10 10 
DM + HT 20 20 
DM + CKD 1 1 
DM + AKI 1 1 
Trauma 4 4 
Total 100 100 
P value 
One Sample Z-Test 0.0001 
 
Type II Diabetes Mellitus was found to be the commonest co-morbid 
condition (n=59, 59%) in patients of NF. Using one sample Z test P- value was 
59
10
20
1 1
4 4
Co-Morbid Conditions
Diabetes Mellitus Hypertension Diabetes, Hypertension
DM, CKD DM,AKI Trauma
Idiopathic
47 
 
determined as 0.0001 and was found to be lower than 0.05, hence association 
of  type II DM is considered statistically significant in patients of NF.  
Frequency of Isolates based on Microbiological classification: 
Figure 5 
 
 
Frequency of Isolates based on Microbiological classification: (n=95) 
Table:14 
Microbial Isolates (n=95) Frequency Percentage 
Monomicrobial 69 72.63 
Polymicrobial 26 27.34 
Total 100 100 
P value 
One Sample Z-Test 0.0414 
 
Monomicrobial isolates (n=69, 69%) were more frequent than 
polymicrobial isolates (n=26, 26%). The distribution of monomicrbial isolates 
69
26
5
Monomicrobial
Polymicrobial
No Growth
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is considered statistically significant since the one sample Z test showed P- 
value of 0.0414 which was  lower than the significant level (0.005). 
Figure 6 
 
Distribution of Aerobes and Anaerobes: (n=123) 
Table:15 
Organisms 
Isolated (n=123) 
Frequency Percentage 
Aerobes 110 89.43 
Anaerobes 13 10.57 
Total 123 100 
 
110
13
Distribution of Aerobes and Anaerobes
Aerobes
Anaerobes
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Figure 7 
 
Frequency Of Aerobic Isolates: (n=110) 
Table:16 
Organisms isolated Frequency Percentage 
Staphylococcus aureus 12 10.9 
Enterococcus feacalis 4 3.63 
Escherichia coli 8 7.27 
Klebsiella pneumonia 32 29.09 
Klebsiella oxytoca 11 10 
Proteus mirabilis 17 15.45 
Proteus vulgaris 7 6.36 
Pseudomonas aeruginosa 16 14.54 
Acinetobacter baumanni 3 2.72 
Total 110 100 
P value 
One Sample Z - Test 
 
0.0081 
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Figure 8
 
Frequency Of aerobic Gram positive cocci isolated:(n=16) 
Table:17 
 
Gram Positive Cocci (n=16) No.of Isolates % 
Enterococcus feacalis 4 25.00 
Staphylococcus aureus 12 75.00 
Total 16 100 
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Figure 9 
 
Frequency Of aerobic Gram negative organisms Isolated: (n=94) 
Table:18 
Gram negative Isolates 
(n=94) Frequency Percentage 
Escherichia coli 8 8.51 
Klebsiella pneumonia 32 34.04 
Klebsiella oxytoca 11 11.70 
Proteus mirabilis 17 18.09 
Proteus vulgaris 7 7.45 
Pseudomonas 
aeruginosa 16 17.02 
Acinetobacter baumanni 3 3.19 
Total 94 100 
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Figure 10 
 
 
Distribution Of Anaerobes: (n=13) 
Table:19 
Anaerobes Isolated (n=13) Frequency Percentage 
Bacteroides fragilis 8 61.54 
Peptostreptococcus anaerobius 5 38.46 
Total 13 100 
 
 
 
 
 
8
5
Distribution Of Anaerobes:
Bacteroides fragilis
Peptostreptococcus 
anaerobius
53 
 
Figure 11 
 
 
Distribution Of Monomicrobial Isolates: (n=69) 
Table:20 
Monomicrobial Organism Isolated (n=69) Frequency Percentage 
Klebsiella pneumoniae 18 26.09 
Klebsiella oxytoca 7 10.14 
Proteus mirabilis 12 17.39 
Proteus vulgaris 4 5.80 
Escherichia coli 8 11.59 
Pseudomonas aeruginosa 12 17.39 
Acinetobacter baumanni 2 2.90 
Staphylococcus aureus 4 5.80 
Enterococcus feacalis 2 2.90 
Total 69 100 
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Figure 12 
 
 
Distribution Of Polymicrobial Isolates: (n=42) 
Table:21 
Polymicrobial Organism Isolated (n=42) Frequency Percentage 
Klebsiella pneumoniae 14 33.33 
Klebsiella oxytoca 4 9.52 
Proteus mirabilis 7 16.67 
Proteus vulgaris 3 7.14 
Escherichia coli 0 0.00 
Pseudomonas aeruginosa 4 9.52 
Acinetobacter baumanni 1 2.38 
Staphylococcus aureus 8 19.05 
Enterococcus feacalis 1 2.38 
Total 42 100 
P Value 
One Sample Z- test 110 0.0081 
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Klebsiella pneumoniae was the most common organism isolated in both 
monomicrobial (n=18, 26.08%) and polymicrobial (n=14, 33.33%) isolates. 
Distribution of Klebsiella pneumoniae showed a P-value of 0.0081 by one 
sample Z test, and is taken as statistically significant. 
Figure 13 
 
Frequency Distribution Of Site Of Infection: (n=100) 
Table:22 
Site of infection (n=100) Frequency Percentage 
Hand 2 2.00 
Inguinal Region 1 1.00 
Perianal 1 1.00 
Perineum 11 11.00 
Thigh 2 2.00 
Lower limb 73 73.00 
Foot 10 10.00 
Total 100 100 
P value 
One Sample Z-Test 
0.0133 
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 Lower limb (n=73, 73%) was the most common site affected in the 
study population. P-value by one sample Z test was 0.0133 (< 0.05). Hence it is 
considered as statistically significant. 
 
Figure 14 
 
 
Frequency Of Extended Spectrum Beta Lactamase (ESBL) Producers: 
(n=68) 
Table:23 
ESBL Production 
(n=68) 
Frequency Percentage 
Present 54 79 
Absent 14 21 
Total 68 100 
P-value 
One Sample Z test 
0.0310 
Figure 15 
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Distribution Of ESBL Producers: (n=54) 
Table:24 
ESBL ESBL Positive Percentage 
Escherichia coli 6 11.11 
Klebsiella oxytoca 10 18.52 
Klebsiella pneumoniae 22 40.74 
Proteus mirabilis 16 29.63 
Total 54 100 
 
Klebsiella pneumoniae (n=22, 40.74%) contributed to most of ESBL 
isolates. By one sample Z test p-Value was 0.0310 which was lower than the 
significance level 0.05, hence this is considered to be statistically significant. 
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Figure 16 
 
Frequency Of MRSA and MSSA: (n=12) 
Table:25 
Staphylococcus aureus (n=12) Frequency Percentage 
MRSA 5 41.67 
MSSA 7 58.33 
Total 12 100 
P value 
One Sample Z-Test 
0.0169 
MSSA
58%
MRSA
42%
Frequency Of MRSA and MSSA
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Of the 12 Staphylococcus aureus isolates, n=5, 41.67% were MRSA and 
n=7, 58.33% were MSSA, Using one sample Z test P-value was calculated. 
Since it was 0.0169, it is statistically significant. 
Vancomycin Sensitivity OF MRSA isolates: (n=5) 
Table:26 
Vancomycin MRSA 
Sensitive (MIC <2µg) 5 
Intermediate (MIC 4-8µg) 0 
Resistant (MIC 16µg) 0 
Total 5 
 
All the MRSA isolates were sensitive to vancomycin by E-test. 
  
60 
 
Figure 17 
 
Antibiotic Susceptibility Pattern of Klebsiella pneumoniae: (n=32) 
Table:27 
Antibiotic Susceptibility - 
Klebsiella pneumonia (n=32) Sensitive (%) Resistant (%) 
Amikacin 56 44 
Gentamicin 44 56 
Ciprofloxacin 38 62 
Cefotaxime 28 72 
Ceftazidime 28 72 
Cotrimoxozole 50 50 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 18 
 
 
Antibiotic Susceptibility Pattern of Klebsiella oxytoca: (n=11) 
Table:28 
Antibiotic Susceptibility - 
Klebsiella oxytoca (n=11) Sensitive (%) Resistant (%) 
Amikacin 64 36 
Gentamicin 27 73 
Ciprofloxacin 18 82 
Cefotaxime 0 100 
Ceftazidime 0 100 
Cotrimoxozole 27 73 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 19 
 
 
Antibiotic Susceptibility Pattern of Proteus mirabilis: (n=17) 
Table:29 
Antibiotic Susceptibility - 
Proteus mirabilis (n=17) Sensitive (%) Resistant (%) 
Amikacin 53 47 
Gentamicin 12 88 
Ciprofloxacin 12 88 
Cefotaxime 6 94 
Ceftazidime 6 94 
Cotrimoxozole 18 82 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 20 
 
 
Antibiotic Susceptibility Pattern of Proteus vulgaris: (n=7) 
Table:30 
Antibiotic Susceptibility - 
Proteus vulgaris (n=7) 
Sensitive (%) Resistant (%) 
Amikacin 29 71 
Gentamicin 0 100 
Ciprofloxacin 0 100 
Cefotaxime 0 100 
Ceftazidime 0 100 
Cotrimoxozole 0 100 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 21 
 
 
Antibiotic Susceptibility Pattern of Escherichia coli: (n=8) 
Table:31 
Antibiotic Susceptibility - 
Escherichia coli (n=8) Sensitive (%) Resistant (%) 
Amikacin 100 0 
Gentamicin 75 25 
Ciprofloxacin 38 62 
Cefotaxime 25 75 
Ceftazidime 38 62 
Cotrimoxozole 63 37 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 22 
 
Antibiotic susceptibility of Pseudomonas aeruginosa: (n=16) 
Table:32 
Antibiotic Susceptibility - 
Pseudomonas aeruginosa 
(n=16) 
Sensitive (%) Resistant (%) 
Amikacin 44 56 
Gentamicin 6 94 
Ciprofloxacin 0 100 
Cefotaxime 0 100 
Ceftazidime 13 87 
Cotrimoxozole 0 100 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 23 
 
 
Antibiotic Susceptibility Pattern of Acinetobacter baumanni: (n=3) 
Table:32 
Antibiotic Susceptibility - 
Acinetobacter baumanni (n=3) Sensitive (%) Resistant (%) 
Amikacin 33 67 
Gentamicin 33 67 
Ciprofloxacin 33 67 
Cefotaxime 33 67 
Ceftazidime 33 67 
Cotrimoxozole 33 67 
Imipenem 100 0 
Piperacillin-Tazobactam 100 0 
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Figure 24 
 
 
Antibiotic Susceptibility Pattern of Staphylococcus aureus: (n=12) 
Table:33 
Antibiotic Susceptibility - 
Staphylococcus aureus (n=12) Sensitive (%) Resistant (%) 
Penicillin 58 42 
Erythromycin 58 42 
Cotrimoxozole 58 42 
Amikacin 58 42 
Gentamicin 58 42 
Ciprofloxacin 58 42 
Cefoxitin 58 42 
Chloromphenicol 50 50 
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Figure 25 
 
 
Antibiotic Susceptibility Pattern of Enterococcus feacalis: (n=4) 
Table:34 
Antibiotic Susceptibility - 
Enterococcus feacalis (n=4) 
Sensitive (%) Resistant (%) 
Penicillin 0 100 
Ampicillin 0 100 
High level gentamicin 0 100 
Vancomycin 100 0 
Chloromphenicol 100 0 
Tetracycline 0 100 
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Antibiotic susceptibility Pattern Of Aerobic Gram Negative Isolates: 
(n=94) 
Table:35 
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Antibiotic susceptibility Pattern Of Aerobic Gram Positive Isolates: 
(n=16)) 
 
Table:36 
Antibiotic Susceptebility of Aerobic 
Gram  Positive Cocci (n=16) 
Staphylococcus 
aureus (n=12) 
Enterococcus 
feacalis (n=4) 
Sensiti
ve (%) 
Resista
nt (%) 
Sensiti
ve (%) 
Resista
nt (%) 
Penicillin 58 42 0 100 
Ampicillin - - 0 100 
Erythromycin 58 42 - - 
Cotrimoxozole 58 42 \- - 
Amikacin 58 42 - - 
Gentamicin 58 42 - - 
High Level Gentamicin - - 0 100 
Ciprofloxacin 58 42 - - 
Cefoxitin 58 42 - - 
Chloromphenicol 50 50 100 0 
Vancomycin - - 100 0 
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Figure 26 
 
OUTCOME: (n=100) 
Table:37 
Outcome Frequency Percentage 
Improved 93 93% 
Amputated 5 5% 
Expired 2 2% 
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Peptostreptococcus anaerobius 
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DISCUSSION 
This is a cross sectional study conducted in the Institute of Microbiology 
in association with the Institute of General surgery at Madras Medical College, 
Chennai. Duration of the study was one year and study population was one 
hundred patients of Necrotising Fasciitis. 
Necrotising fasciitis was found to be more common in males than the 
female population. Out of the one hundred patients included in this study of the 
population males (n=76), 76% were more commonly affected by Necrotising 
Fasciitis. Females constituted (n=24), 24% of the study population. The peak 
incidence of NF was observed in patients aged between 51-60 years, which 
accounted for 24% of the study population. The mean age group was 58.35 
years.  
In this study extremities were more frequently affected sites, which was 
around 85%, of which lower limb happened to be the most common site which 
was involved in 83% of the patients.   Scrotum (Fournier’s gangrene) was 
affected in 11% of the patients. Increased frequency of lower limb infection 
corresponds to the fact that most of the patients were diabetics who were 
predisposed to lower limb infections. High blood sugar levels and low oxygen 
tension favours bacterial growth.        
Tang et.al in their study series of 24 patients with necrotizing fasciitis of 
the limbs, had documented lower limb involvement in 12 patients. (53). Wong 
et.al in their study series of 89 patients, estimated that 70% of them had lower 
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limbs NF. (54)   The preponderance of lower limb infection in the present study 
correlates with these studies. 
In the present study, Type II or monomicrobial aetiology were found to 
be higher constituting 69% of infections and Type I,  polymicrobial infections 
corresponded to 26% of infections. No growth was observed in specimens 
collected from five (5%) of the patients. 
Some of the studies had reported significant rise in the incidence of 
monomicrobial infections. Ming- Jong Bair et al in a study had described that 
two third of infections were of monomicrobial aetiology. (55)  
Yaug-Meng Liu et al has also showed 67.8% of monomicrobial agents 
as primary cause of Necrotising Fasciitis. (56). D. Yadhav et al had 
retrospectively studied 45 patients with necrotising fasciitis documented to be 
of monomicrobial aetiology. (57) 
Yao-Hung Tsai et al in a retrospective study had reported higher 
incidence (70.6%) of monomicrobial infection. (58). The documentation of 
higher number of monomicrobial aetiological agent in this study is comparable 
with the other Asian studies. 
Among the 69% of patients with monomicrobial infections, Gram 
negative bacilli were predominantly isolated in these patients. 
Enterobacteriaceae family members were the common isolates which 
constituted around 71%. Gram positive cocciisolated were Staphylococcus 
aureus, 10.9% and Enterococcus feacalis, 3.63%.  Non- fermenters like 
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Acinetobacter baumanni and Pseudomonas aeruginosa, also accounted for 
2.8% and 17.3% respectively as monomicrobial agents causing NF. Klebsiella 
pneumoniae was the common isolate constituting 26% of monomicrobial 
infections.  
P- value obtained for monomicrobial growth by one sample Z test was 
0.0414. Hence this is taken as statistically significant as this is lower than the 
significant value (0.05). 
Patients with polymicrobial aetiology also had Enterobactriaceae 
members as the common pathogen with frequency of 66%. Klebsiella 
pneumonia showed a frequency of 33.3% isolate. Staphylococcus aureus 
19.05% was isolated in patients with polymicrobial infections. 
Yuang-Meng Liu et al in their study has depicted that Enterobactriaceae 
were the frequent pathogens, with K. pneumoniaebeing the most common 
organism isolated. (56). Though type I polymicrobial necrotising fasciitis has 
been the cause of 80% of cases as shown by several of the studies, there has 
been a substantial increase in incidence of monomicrobial necrotising fasciitis 
evident from recent studies. (59, 60).    
In this study Klebsiella pneumoniae was the common organism isolated 
constituting of about 29.09% of the total isolates, followed by 15.45% of 
Proteus mirabilis, 14.54% of Pseudomonas aeruginosa,and 10.9% of 
Staphylococcus aureus. 
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Enterococcus feacalis3.63%, Klebsiella oxytoca10%, Proteus vulgaris 6.36%, 
Acinetobacter baumanni 2.72%, were the other pathogens which were 
relatively less frequent in the present study.   
Klebsiella pneumonia, E.coli, Vibrio vulnificus, Aeromonas hydrophila 
were reported to be the most common isolates in Asia. (61, 62).  Fazal et al in 
their case series had reported 50.3% of Klebsiella spp infections. (2). 
Mixed aerobic and anaerobic infection constituted about 50% of the 
polymicrobial infections. Mathew et al in their study had isolated 11.1% of 
mixed aerobic and anaerobic bacteria. (63). Kreig et al retrospectively analysed 
patients with necrotising fasciitis between the year 1996 and 2005 and had 
reported that the cultures of 30.8% of the patients with type I polymicrobial 
infection also had anaerobes as synergistic pathogens. (64)   
        Of the one hundred patients, 13% had anaerobic infections. 61.5% was 
due to Bacteroides fragilis and 38.4% had Peptostreptococcus anaerobius 
infection. The virulence factors of these anaerobes had been documented in 
clinical infections. (65, 66). Several hypothesis had been proposed to substantiate 
such microbial synergy. (67). 
The synergy of bacteria may be explained by the following mechanisms; 
(a)Due to mutual protection from phagocytosis and intracellular killing, (68) 
(b) Production of essential growth factors, (69)  
(c) Reduction of oxidation-reduction potential in host tissues, (70). 
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Type II diabetes was found to be the most frequent co-morbid condition 
associated with necrotising fasciitis accounting for 59% of the study 
population. Patients with both diabetes and hypertension constituted to 20%. 
One patient had type II diabetes mellitus with acute kidney injury. Type II DM 
with chronic Kidney disease was found in one patient. Out of the total one 
hundred patients, 4% of the patients had trauma as the main predisposing factor 
for NF and 10% had hypertension alone as co-morbidity. 5% of the study 
population presented with idiopathic necrotising fasciitis.   
Several of the studies had analysed that Type II DM as the most 
common comorbid condition. Madhumita et al in a prospective study had 
reported Type II diabetes as the commonest co-morbidity. (71). Yeung et al in 
their retrospective study had documented Type II DM as the frequent 
comorbidity. (72).  
The above quoted studies had documented results that are comparable to 
this study. Type II DM has been documented as co-morbidity in 59%, (n=59%) 
of study population. P- Value calculated using one sample Z test was 0.0001, 
hence the association of type II DM and NF is statistically significant.         
Trauma had been documented as a predisposing factor in 36.25% of the 
patients by Mathew et al. (63). Nissar shaikh in his retrospective study had 
documented trauma as a predisposing Condition in 10% of the patients. (73). 4% 
of patients had trauma as predisposing factor in this study.  
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Garg et al in a prospective study had reported several patients of 
necrotising fasciitis with no predisposing factors (Idiopathic NF). (74). In the 
present study 5%of the patients presented with idiopathic necrotising fasciitis. 
Klebsiella pneunomiae  (n=32) were 56% sensitive to Amikacin, 44% 
sensitive to Gentamicin, 38% sensitive to ciprofloxacin, 50% sensitive to Co-
trimoxozole and 28% sensitive to both cefotaxime and ceftazidime. 
Out of the 12 isolates of Staphylococcus aureus 58% were sensitive to 
Penicillin, Erythromicin, Ciprofloxacin, Amikacin, Gentamicin, Co-
trimoxozole. 50% were sensitive to Chloromphenicol. 
Out of the 32 isolates of Klebsiella pneumoniae, 22 (40.74%) were 
Extended Spectrum Beta-Lactamase (ESBL) producers. 17  Proteus mirabilis 
were isolated, out of which 16 (29.63%) were ESBL producers. 11 Klebsiella 
oxytoca were isolated and 10 (18.52%) were found to produce ESBL. Of the 8 
isolates of Escherichia coli 6 (11.11%) were ESBL producers. 
    By one sample Z test P-value was found to be 0.310 (lower than 
significant value 0.05) is considered to be statistically significant. 
        Anaya et al had had reported that 21.7% isolates of Staphylococcus 
aureus in patients of necrotising fasciitis. (1). Angoules et al in their study had 
reported the presence of Staphylococcus aureus in 18.9% of the patients with 
necrotising fasciitis. (75). The results of these studies corresponds to the results 
obtained in the present  study. P-value obtained was 0.0169 by one sample Z 
test. This is taken as statistically significant. 
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         Out of the 12 Staphylococcus aureus isolates, 5 (41.6%) were MRSA 
and 7 (58.3%) were MSSA. Chaun et al in a retrospective study had analysed 
and reported predominance of MSSA and MRSA isolates. (76). Miller et al, in a 
retrospective study conducted in Los Angeles, had described 14 cases of 
Methicillin Resistant Staphylococcus aureusfound to produce Panton valentine 
Leukocidin toxin, as the etiological agent of Necrotising fasciitis. (77). Maltezou 
et al had documented MRSA causing necrotising fasciitis. (78).  
Two patients (2%) with Klebsiella pnemoniae infection expired, out of 
one hundred patients included in the study. High mortality rate which was 
around 60% with Klebsiella pneumonia has been documented in a retrospective 
study by Yao-Hung Tsai. (58). 
Several of the patients serially underwent two to three debridements 
during their hospital stay. Duration of hospitalisation of patients happened to be 
around thirty to forty five days in average. Five of the patients (5.1%) 
underwent below knee amputation. Out of the five patients four were diabetics 
and one other patient was a non- diabetic. Other patients improved during the 
course of their hospital stay. 
Ramin et al in their study had reported significantly higher amputation 
(71.4%) in diabetics than in non-diabetics. (79). 
All the patients received intravenous fluids and broad spectrum 
intravenous antibiotics. The antibiotics administered, included Piperacillin-
Tazobactam, Metronidazole, Imipenem. Clindamycin, Imipenem and 
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combination of Penicillin and β-lactamase inhibitor target against anaerobic 
organisms. Imipenem, Piperacillin-Tazobactam combination also provides 
coverage for Enterobacteriaceae family members, and Staphylococcus aureus. 
In the present study, Klebsiella pneumoniae, Klebsiella oxytoca,Proteus 
mirabilis, Proreus vulgaris, Escherichia coli,Pseudomonas 
aeruginosa,Acinetobacter baumanni were all 100% sensitive to Imipenem and 
Piperacillin-Tazobactam.  
MRSA isolates were all sensitive to Vancomycin by Minimal inhibitory 
Concenteration by E-test. 
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SUMMARY 
 This cross-sectional study was conducted at the Institute of 
Microbiology in association with the Institute of General Surgery, 
which included a study population of one hundred patients with 
Necrotising Fasciitis. 
 Necrotising Fasciitis was common in males than in females included 
in the study population between the age group of 51-60 years. 
 Lower limb was the frequent site of infection involved in majority of 
the patients and type II diabetes mellitus was the predominant co-
morbid condition associated with necrotising fasciitis. 
 Ninety five percentage of the growth obtained were aerobes and 
thirteen percentage were mixed aerobic and anaerobic infections. 
 Enterobacteriaceae were the common isolates, of which Klebsiella 
pneumoniae was the most common pathogen isolated followed by 
Proteus mirabilis. 
 Bacteroides fragilis was the predominant anaerobe isolated. 
 Klebsiella pneumoniae was the predominant ESBL producer followed 
by Proteus mirabilis. 
 Forty one percentage of Staphylococcus aureus were found to be 
Methicillin Resistant. 
 All the Gram negative bacilli were sensitive to Imipenem and 
Piperacillin-Tazobactam.  
 MRSA isolates were all sensitive to Vancomycin by E-test. 
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CONCLUSION 
Necrotising Fasciitis is a rapidly progressing lethal condition where high 
degree of clinical suspicion, prompt diagnosis and intensive surgical and 
medical therapy by health care professionals should be the ultimate agenda to 
reduce morbidity and mortality. This study has documented the recent changes 
in the trend and frequency of bacteria causing necrotising fasciitis, which 
would be of immense assistance in selection and administration of appropriate 
empirical antibiotic therapy before the availability of culture reports. 
Since there has been a remarkable surge in Gram negative 
Enterobacteriaceae members causing Necrotising Fasciitis, recognition of their 
antibiotic susceptibility pattern would offer a productive insight in affording 
potentially better medical therapy, in addition to the extensive surgical therapy. 
This would also aid in enhancement of recovery of the patients and thus 
limiting their duration of hospital confinement. 
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APPENDIX – I 
ABBREVIATIONS 
NF  – Necrotising Fasciitis 
NSTI  – Skin and soft-tissue infection 
PBSG  – Progressive Bacterial Synergistic Gangrene 
MODS – Multi- Organ Dysfunction Syndrome 
CLSI – Clinical & Laboratory Standards Institute 
ATCC  -– American Type Culture Collections 
MIC – Minimum Inhibitory Concentration 
MRSA – Methicillin Resistant Staphylococcus aureus 
MSSA – Methicillin Sensitive staphylococcus aureus  
PVL – Panton Valentine leukocidin 
ESBL – Extended Spectrum Beta Lactamase 
SPS –  Sodium Polyanetholsulfate 
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APPENDIX II 
(1) Cation adjusted Mueller- Hinton Agar 
Beef infusion 300ml 
Caesein hydrolysate 17.5g 
Starch 1.5g 
Agar l0g 
Distilled water litre 
pH = 7.4 
Sterilise by autoclaving at 121°C for 20 mins 
(2) Robertson's Cooked Meat Broth 
Fresh bullock heart 5 00g 
Water 500ml 
Sodium hydroxide, lmol/1 1.5ml 
Liquid filtered from cooked meat 500ml 
Peptone 2.5g 
NaCl 1.25g 
(3) Selective Anaerobic Blood Agar: 
1 μg/ml menadione and 20 μg/ml gentamicin added to the blood agar. 
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ANNEXURE – I 
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                                                 ANNEXURE – II 
                                                    PROFORMA 
Name:                                                      IP No:______________________ 
Age:Ward:______________________ 
Sex: M / F 
Occupation: 
Address:________________________________________________________
_ 
_______________________________________________________________
_ 
Presenting complaints: 
    Ulcers associated with pain and discharge 
General examination: 
     Febrile/Afebrile 
     Icterus: Present/absent 
Local examination: 
    Ulcers with erythema, oedema, blisters 
Nature of discharge-purulent/watery 
     Presence of necrotic tissue 
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     Depth of the ulcer 
Provisional diagnosis: 
Laboratory evaluation 
Microbiological investigation: 
Samples collected: 
Swab from the deeper areas of the ulcers (OR) 
Tissues obtained during wound debridement. 
Direct examination 
Gram’s Stain: 
Aerobic and anaerobic culture:  
Mac Conkey agar plate 
Blood agar plate 
Identification of Isolates 
Antibacterial susceptibility pattern 
 
 
 
  
92 
 
ANNEXURE – III 
CONSENT FORM 
STUDY TITLE: A study on Bacteriological Profile of Necrotising Fasciitis in a 
tertiary care hospital.” 
I…………………………………………, hereby give consent to participate in 
the study conducted by Dr.G.k.Asha, Post graduate at Institute of 
Microbiology, Madras Medical College, Chennai and to use my personal 
clinical data and the result of investigations for the purpose of analysis and to 
study the nature of the disease, I also give consent to give my sample for 
further investigations. I also learn that there is no additional risk in this study. I 
also give my consent for my investigator to publish the data in any forum or 
journal. 
Signature/ Thumb impression of the patient/ relative 
Patient Name & Address: 
Place: 
Date: 
 
Signature of the investigator    Signature of the guide 
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Keys to Master Chart 
Ak – Amikacin 
Gen  – Gentamicin 
Cip – Ciprofloxacin 
Cotri – Cotrimoxozole 
Cef – Cefotaxime 
CAZ – Ceftazidime 
Imi – Imipenem 
PT – Piperacillin-Tazobactam 
Pen – Penicillin 
Ery – Erythromicin 
HLG – High level gentamicin 
Van – Vancomycin 
Ck – Chloromphenicol 
Tetra – Tetracyclin 
S – Sensitive 
R – Resistant 
(-) – Not applicable 
